Insurers, pharmacy benefit managers driving up drug costs
      CommonWealth Magazine, 8/22/19

When drug prices jump, so does Trump — if he sees it on the news
      Bloomberg Law, 8/13/19

Generic drugs 'wildly overpriced' in Medicare, study finds
      Becker’s Hospital Review, 7/15/19

The Wild West of generic drugs in Medicare
      Axios, 7/15/19

Generics prices aren't falling like they used to
      Axios, 7/2/19

Two more big states take aim at PBM pricing practices, which one lawmaker calls ‘the wild west’
      STAT News, 6/5/19

PolitiTalk Podcast featuring Antonio Ciaccia
      PolitiTalk Podcast, 5/16/19

As Trump’s drug plan turns one, prices drop but future unclear
      Bloomberg Law, 5/13/19

Bellbrook man’s data crunching driving big pharmacy change
      Dayton Daily News, 5/13/19

Medicaid managed care programs’ contracts for generic drugs are inefficient
      Health Affairs, 5/1/19

Ohio Medicaid officials to crack down on PBM specialty drug practice
      Columbus Dispatch, 4/30/19

Questions raised on how pharmacy benefit managers profit from specialty drugs
      Columbus Dispatch, 4/24/19

The questionable ties between pharmacy benefit managers and specialty pharmacies
      Axios, 4/24/19

Specialty drugs: The new arena for pharmacy benefit manager profits?
      Columbus Dispatch, 4/23/19

Ohio AG calls for ‘immediate legislative action’ against PBMs
      Inside Health Policy, 4/22/19

Andy Beshear investigating suspected state Medicaid drug price gouging
      Louisville Courier Journal, 3/22/19

Webinar: Tools you can use to dig into national prescription drug pricing
      The Council of Insurance Agents & Brokers, 3/21/19

Overcharges on generic Prilosec give Ohio taxpayers heartburn
      Columbus Dispatch, 3/10/19

FDA chief's resignation greeted mostly by surprise, praise
      MedPage Today, 3/6/19

Lilly to introduce generic insulin drug that slashes price 50 percent
      Indianapolis Star, 3/4/19

How lawmakers could pressure top pharma execs in Senate hearing
      BioPharma Dive, 2/25/19

Sanofi handed payers nearly $12B in drug rebates last year
      BioPharma Dive, 2/21/19

Amazon’s latest target is pharmacy disruption
      Indianapolis Business Journal, 2/21/19

Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
      FiercePharma, 2/15/19

Drug company raises price of pain reliever by 70%
      Axios, 2/14/19

A costly oversight: the ongoing impact of the Valsartan recall
      Pharma Technology Focus, 2/1/19

Pfizer, Novartis, Amgen add to 2019 drug price hikes
      BioPharma Dive, 1/25/19

The Midterm’s Biggest Winners: Medicaid And Rural America
      Health Affairs, 1/25/19

Generic drug prices drop: 4 notes
      Becker’s Hospital Review, 1/25/19

Pharmacy benefit managers marked up generic drugs for NY Medicaid, but where’d the money go?
      Pharmalot via STAT News, 1/24/19

Brand-name drug price hikes are fewer, but still above inflation
      Becker’s Hospital Review, 1/22/19

Drug makers still raising prices, but seeking fewer hikes
      Axios, 1/22/19

Soaring prescription drug prices 'one of the hottest political issues in 2019'
      Indianapolis Star, 1/17/19

Prescription drug pricing strategy: Where is the money going?
      Boston 25 News, 1/14/19

Prescription look-up tool helps you get closer to actual cost of drugs
      Columbus Dispatch, 1/13/19

This bottle of pills costs $20 in one state and $130 in another
      Bloomberg, 1/4/19

Pennsylvania auditor recommends new laws to crack down on PBM contracts for Medicaid
      Pharmalot via STAT News, 12/11/18

The drug pricing maze
      Axios, 11/17/18

Are you paying too much for prescriptions? This tool will help you find out
      Columbus Dispatch, 10/29/18

Kaiser Family Foundation annual survey: Medicaid signups flat, spending higher on prescription drugs and addiction care
      USA Today, 10/25/18

Prescription Drug Price Look Up
      Columbus Dispatch, 10/24/18

Cost of blood pressure drug surges in U.S. after recall
      Reuters, 10/16/18

Side Affects podcast: 46brooklyn
      Side Affects with McGohan Brabender, 10/1/18

Generic drug prices ⬇️
      Axios, 9/21/18

Trying to bring transparency and accountability to prescription drug prices to help lower costs for patients
      The Capitolist, 9/20/18

John Arnold: Are pharmacy benefit managers the good guys or bad guys of drug pricing?
      STAT News, 8/27/18

Ohio Medicaid drug audit calls for transparency, highlights pharmacy closures
      Columbus Dispatch, 8/16/18

Ohio Medicaid cancels contracts with two big PBMs over ‘spread’ pricing
      Pharmalot via STAT News, 8/14/18

States question costs of middlemen that manage Medicaid drug benefits
      NPR, 8/8/18

Pharmalittle: Curious to know what a pharmacy benefit manager charges state Medicaid programs for drugs and what those same medicines cost pharmacies?
      Pharmalot via STAT News, 8/7/18

New site compares Medicaid drug prices across states and overall drug price trends
      Connecticut Health Policy Project, 8/2/18

The data showing drug pricing games
      Axios, 8/1/18


To learn more about our initial road to seeking drug price transparency, we recommend reading up on the drug pricing controversies in Ohio, where 46brooklyn’s data work sparked a massive investigation into hidden middleman mark-ups. For a complete rundown on what unfolded in Ohio, check out the outstanding Side Effects series from the Columbus Dispatch.